Asthma Attacks Could Be Reduced With Two-Drug Inhaler

Two drugs are better than one when it comes to stopping asthma attacks in progress, a new clinical trial has found.

The study, of more than 3,100 asthma patients, found that a two-drug “rescue” inhaler worked better than a standard inhaler in thwarting severe asthma exacerbations — helping some patients avoid trips to the hospital.

The inhaler, which is not yet approved, contains two long-used asthma medications: albuterol and budesonide.

Budesonide is a corticosteroid that controls the airway inflammation underlying asthma; people with the disease commonly use a daily inhaler containing a corticosteroid (one brand is Pulmicort) to prevent attacks of wheezing, coughing and breathlessness.

That’s in contrast to standard rescue inhalers, which are used to quickly quell a symptom flare-up. They contain medications called short-acting beta-agonists and work by relaxing and widening the airways. Short-acting beta-agonists include albuterol (branded as ProAir).

In the new trial, researchers found that combining budesonide and albuterol into one rescue inhaler appears to be the better approach. On average, the two-drug inhaler cut patients’ risk of a severe symptom attack by 26%, versus albuterol alone.

Experts said they think the new inhaler, if approved, should become the rescue medication of choice for most asthma patients.

“Current rescue therapy certainly works, but it’s not the best,” said Dr. Reynold Panettieri Jr., one of the researchers on the trial.

That’s because while standard inhalers open the airways, they do not address inflammation, explained Panettieri, a professor of medicine at Rutgers Robert Wood Johnson Medical School in New Brunswick, N.J.

The dual-drug inhaler gives people a dose of corticosteroids “right when they need it most,” Panettieri said.

That does not mean the new rescue inhaler could replace corticosteroids used for daily asthma control: Patients in the trial were taking controller medications, and used the rescue inhaler “as needed” when symptoms flared.

The two-drug approach makes sense, as it adds the missing piece of targeting inflammation, agreed Dr. Michael Wechsler, who directs the Cohen Family Asthma Institute at National Jewish Health in Denver.

Wechsler, who was not involved in the trial, said that if the inhaler is approved, he sees it largely replacing standard rescue inhalers.

“I believe it should become the treatment of choice,” he said, “especially for patients with a history of asthma exacerbations.”

The findings were published May 15 in the New England Journal of Medicine, and presented at the American Thoracic Society’s annual meeting, in San Francisco. The U.K. drug company Avillion, which is developing the two-drug approach with AstraZeneca, provided the funding.

The trial involved 3,132 patients, mostly adults and teenagers, who had moderate-to-severe asthma. They were randomly assigned to use either the two-drug rescue inhaler or albuterol only, as needed, for at least six months.

Overall, patients using the medication duo were less likely to suffer a severe asthma attack — defined as ending up in the emergency room or hospital, or needing to take oral or injection corticosteroids for at least three days.

On average, the annual rate of severe attacks was one-quarter lower among patients on the two-drug inhaler, versus those using albuterol alone.

In managing asthma, the goal should always be minimizing the need for a rescue inhaler, said Dr. Mark Jacobson, medical director of Allergy & Asthma Physicians in Hinsdale, Ill. That means making sure patients are on an optimal dose of controller medication, and educating them on avoiding triggers, he said.

“All that being said, when individuals do have an exacerbation, it will most certainly include a significant amount of inflammation,” said Jacobson, who was not involved in the trial.

“Therefore, when they do have symptoms it would certainly be helpful to get some inhaled steroids into them,” he said.

Like Wechsler, Panettieri believes the two-drug inhaler could replace standard treatment.

“I think this could be a game-changer,” he said.

There is, however, the real-world issue of cost, Panettieri pointed out. It’s not clear how expensive the two-drug inhaler would be. But if it costs substantially more than standard rescue inhalers, insurers might balk — though, Panettieri said, there would be savings from avoiding some ER trips and hospitalizations.

The inhaler also needs to be tested more extensively in children, Panettieri said. There were too few kids younger than 12 in this trial to draw conclusions.

Wechsler said the two-drug inhaler is likely to be effective for children, and the main question will be whether it has any adverse effects. No safety issues turned up among adults and teens in this trial.

More information

The American Academy of Allergy, Asthma and Immunology has more on asthma.

SOURCES: Reynold Panettieri Jr., MD, professor, medicine, vice chancellor, Clinical and Translational Science, Rutgers Robert Wood Johnson Medical School, New Brunswick, N.J.; Michael Wechsler, MD, professor, medicine, director, Cohen Family Asthma Institute, National Jewish Health, Denver; Mark C. Jacobson, MD, medical director, Allergy & Asthma Physicians, Hinsdale, Ill.; New England Journal of Medicine, May 15, 2022, online

What do you think?


Leave a Reply
  1. An impressive share! I’ve just forwarded this onto a coworker who was doing a little homework on this. And he actually bought me breakfast because I stumbled upon it for him… lol. So allow me to reword this…. Thank YOU for the meal!! But yeah, thanx for spending time to talk about this subject here on your internet site.

  2. I in addition to my buddies have been reading through the excellent tricks located on the website then then got a terrible feeling I never thanked you for those tips. Those women appeared to be thrilled to study them and already have in truth been loving them. We appreciate you indeed being indeed thoughtful as well as for figuring out this form of impressive issues most people are really wanting to understand about. My very own sincere regret for not saying thanks to earlier.

  3. After checking out a number of the articles on your site, I honestly like your technique of writing a blog. I saved it to my bookmark webpage list and will be checking back in the near future. Please visit my website too and let me know what you think.

  4. Its like you read my mind! You seem to know a lot about this, like you wrote the book in it or something. I think that you can do with a few pics to drive the message home a little bit, but instead of that, this is great blog. An excellent read. I will certainly be back.

  5. You are so interesting! I do not think I have read through something like this before. So good to discover someone with a few unique thoughts on this subject matter. Seriously.. thank you for starting this up. This site is something that is needed on the internet, someone with some originality.

  6. 정말 대단한 글입니다 저는토토놀이터에 관한 블로그에 관심이 정말 많습니다.올해 같은 주제의 최고의 정보를 제공하는 글을 체크하는 것은 드뭅니다

  7. Your style is very unique in comparison to other folks I have read stuff from. I appreciate you for posting when you have the opportunity, Guess I’ll just bookmark this page.

  8. Spot on with this write-up, I absolutely feel this site needs a lot more attention. I’ll probably be back again to read through more, thanks for the information.

  9. Next time I read a blog, Hopefully it won’t fail me just as much as this particular one. I mean, I know it was my choice to read, however I truly thought you would have something helpful to talk about. All I hear is a bunch of moaning about something that you can fix if you were not too busy looking for attention.

  10. After exploring a handful of the articles on your web site, I truly appreciate your technique of blogging. I added it to my bookmark website list and will be checking back in the near future. Please visit my web site as well and tell me how you feel.

  11. Hi there, I believe your web site could possibly be having internet browser compatibility issues. When I take a look at your site in Safari, it looks fine however, if opening in I.E., it has some overlapping issues. I just wanted to provide you with a quick heads up! Other than that, wonderful site.

  12. May I simply just say what a comfort to uncover someone that genuinely knows what they’re talking about over the internet. You certainly know how to bring an issue to light and make it important. More and more people should read this and understand this side of the story. I was surprised that you are not more popular because you certainly possess the gift.

  13. Have you ever considered about including a little bit more
    than just your articles? I mean, what you say is important and everything.
    However just imagine if you added some great graphics or video clips to give your posts more, “pop”!
    Your content is excellent but with pics and clips, this blog could certainly be
    one of the greatest in its niche. Very good blog!

Leave a Reply

Your email address will not be published. Required fields are marked *

Study Shows Video Games Boost a Child’s Intelligence

Hospitals Are Now Facing Shortage of Dye Needed for Life-Saving Scans